MAPK3 and cancer: Notably, recent studies have highlighted the pro-apoptotic functions of ERK1/2 kinases and various compounds, including betulinic acid, piperlongumine, and cisplatin, trigger cancer cell death by enhancing ERK1/2 signaling [8,9].